Drugplain

D-90 6 [hp_X]/mL

Silver, Echinacea angustifolia, and Ferrosoferric phosphate · SOLUTION · DNA Labs, Inc.

10 Recalls on Record
Plain English

D-90 is a solution containing silver, echinacea angustifolia, and ferrosoferric phosphate at 6 [hp_X]/mL, taken sublingual. Manufactured by DNA Labs, Inc..

Key Facts

Brand Name
D-90
Generic Name
Silver, Echinacea angustifolia, and Ferrosoferric phosphate
NDC Code (Product)
58264-0096
Manufacturer
DNA Labs, Inc.
Strength
6 [hp_X]/mL
Dosage Form
SOLUTION
Route
SUBLINGUAL
Marketing Status
Marketing Start
01/01/1990

Recall History

10 Recalls on Record
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated
Class II07/27/2021

Perrigo Company PLC

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

TerminatedVoluntary: Firm initiated
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated
Class II01/10/2020

PD-Rx Pharmaceuticals, Inc.

CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.

TerminatedVoluntary: Firm initiated
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated
Class II06/26/2023

Preferred Pharmaceuticals, Inc.

Failed Stability Specifications

OngoingVoluntary: Firm initiated
Class II08/25/2020

RLC Labs Inc.

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

diarrhoea33 reports
pain33 reports
headache30 reports
fatigue29 reports
nausea27 reports
arthralgia26 reports
dizziness25 reports
pain in extremity21 reports
asthenia18 reports
abdominal pain upper17 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS Support to the immune system associated with fatigue.

Dosage & Administration

SUGGESTED DOSAGE One dropper under tongue two times daily. Acute symptoms ½ dropper under tongue every 30 minutes for two hours.

Warnings

Warnings Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children.

Frequently Asked Questions

What is D-90 used for?

D-90 contains Silver, Echinacea angustifolia, and Ferrosoferric phosphate. It is a solution taken sublingual. Consult your doctor for specific uses.

Is D-90 a controlled substance?

D-90 is not classified as a controlled substance by the DEA.

What is the generic name for D-90?

The generic name for D-90 is Silver, Echinacea angustifolia, and Ferrosoferric phosphate. There are no other listed brand versions of Silver, Echinacea angustifolia, and Ferrosoferric phosphate.

What is the NDC code for D-90 6 [hp_X]/mL?

The NDC (National Drug Code) for D-90 6 [hp_X]/mL is 58264-0096, listed by DNA Labs, Inc..

Product NDC

58264-0096

Package NDC

58264-0096-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)